105 related articles for article (PubMed ID: 3982600)
21. Involvement of intracellular Ca2+ stores in 3,4-diaminopyridine-evoked [3H]norepinephrine release.
Huang HY; Zhou CW
Zhongguo Yao Li Xue Bao; 1996 Jul; 17(4):302-5. PubMed ID: 9812707
[TBL] [Abstract][Full Text] [Related]
22. Massive exocytosis triggered by sodium-calcium exchange in sympathetic neurons is attenuated by co-culture with cardiac cells.
Wakade AR; Przywara DA; Bhave SV; Chowdhury PS; Bhave A; Wakade TD
Neuroscience; 1993 Aug; 55(3):813-21. PubMed ID: 8413937
[TBL] [Abstract][Full Text] [Related]
23. The action of excess potassium and calcium on ouabain-evoked [3H]-noradrenaline release from the rabbit pulmonary artery.
Magyar K; Nguyen TT; Török TL; Tóth PT
Br J Pharmacol; 1986 Jan; 87(1):63-71. PubMed ID: 3955302
[TBL] [Abstract][Full Text] [Related]
24. Role of Ca2+ in metabolic inhibition-induced norepinephrine release in rat brain synaptosomes.
Du XJ; Bobik A; Little PJ; Esler MD; Dart AM
Circ Res; 1997 Feb; 80(2):179-88. PubMed ID: 9012740
[TBL] [Abstract][Full Text] [Related]
25. Choline uptake and acetylcholine synthesis in synaptosomes: investigations using two different labeled variants of choline.
Weiler MH; Gundersen CB; Jenden DJ
J Neurochem; 1981 May; 36(5):1802-12. PubMed ID: 7241138
[TBL] [Abstract][Full Text] [Related]
26. The effect of desipramine on ischemia-induced changes in extracellular K+, Na+, and H+ concentrations and noradrenaline release in the isolated rat heart during global ischemia.
Knopf H; Theising R; Hirche H
J Cardiovasc Pharmacol; 1988; 12 Suppl 1():S8-14. PubMed ID: 2468840
[TBL] [Abstract][Full Text] [Related]
27. Release of vesicular noradrenaline in the rat tail artery induced by cocaine.
Palatý V
Naunyn Schmiedebergs Arch Pharmacol; 1988 Nov; 338(5):510-6. PubMed ID: 3244393
[TBL] [Abstract][Full Text] [Related]
28. Sodium dependent 3H-noradrenaline release from rat neocortical slices in the absence of extracellular calcium: presynaptic modulation by mu-opioid receptor and adenylate cyclase activation.
Schoffelmeer AN; Hogenboom F; Mulder AH
Naunyn Schmiedebergs Arch Pharmacol; 1988 Nov; 338(5):548-52. PubMed ID: 2854212
[TBL] [Abstract][Full Text] [Related]
29. Studies on the uptake and release of propranolol and the effects of propranolol on catecholamines in cultures of bovine adrenal chromaffin cells.
Boksa P
Biochem Pharmacol; 1986 Mar; 35(5):805-15. PubMed ID: 3954787
[TBL] [Abstract][Full Text] [Related]
30. Dependence of release of [3H]noradrenaline from rabbit pulmonary artery on internal sodium.
Török TL; Tóth PT; Tóthfalusi L; Azzidani AM; Magyar K
J Physiol; 1992 Dec; 458():11-25. PubMed ID: 1338787
[TBL] [Abstract][Full Text] [Related]
31. Binding of uptake blockers to the neuronal dopamine transporter: further investigation about cationic and anionic requirements.
Corera AT; Costentin J; Bonnet JJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 Sep; 362(3):213-21. PubMed ID: 10997723
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors.
Schlicker E; Fink K; Hinterthaner M; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6):633-8. PubMed ID: 2615855
[TBL] [Abstract][Full Text] [Related]
33. The effects of T-588, a novel cognitive enhancer, on noradrenaline uptake and release in rat cerebral cortical slices.
Maekawa M; Murayama T; Ono S; Narita H; Nomura Y
Jpn J Pharmacol; 1998 Jun; 77(2):155-60. PubMed ID: 9681572
[TBL] [Abstract][Full Text] [Related]
34. Release of norepinephrine from rat hypothalamic slices: effects of desipramine and tyrosine.
Irie K; Wurtman RJ
Brain Res; 1987 Oct; 423(1-2):391-4. PubMed ID: 3676816
[TBL] [Abstract][Full Text] [Related]
35. Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors?
Raiteri M; Bonanno G; Marchi M; Maura G
J Pharmacol Exp Ther; 1984 Dec; 231(3):671-7. PubMed ID: 6150107
[TBL] [Abstract][Full Text] [Related]
36. Norepinephrine uptake dependent upon apparent Mg++-ATPase activity and proton transport in storage vesicles in axoplasm.
Bogdanski DF
Synapse; 1988; 2(4):424-31. PubMed ID: 2973143
[TBL] [Abstract][Full Text] [Related]
37. Protection of neuronal uptake-1 inhibitors in ischemic and anoxic hearts by norepinephrine-dependent and -independent mechanisms.
Du XJ; Woodcock EA; Little PJ; Esler MD; Dart AM
J Cardiovasc Pharmacol; 1998 Oct; 32(4):621-8. PubMed ID: 9781931
[TBL] [Abstract][Full Text] [Related]
38. Dual effect of digitalis glycosides on norepinephrine release from human atrial tissue and bovine adrenal chromaffin cells: differential dependence on [Na+]i and [Ca2+]i.
Haass M; Serf C; Gerber SH; Krüger C; Haunstetter A; Vahl CF; Nobiling R; Kübler W
J Mol Cell Cardiol; 1997 Jun; 29(6):1615-27. PubMed ID: 9220347
[TBL] [Abstract][Full Text] [Related]
39. Ketamine interacts with the noradrenaline transporter at a site partly overlapping the desipramine binding site.
Hara K; Yanagihara N; Minami K; Ueno S; Toyohira Y; Sata T; Kawamura M; Brüss M; Bönisch H; Shigematsu A; Izumi F
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):328-33. PubMed ID: 9774220
[TBL] [Abstract][Full Text] [Related]
40. 3,4-Diaminopyridine-evoked noradrenaline release in rat hippocampus: role of Na+ entry on Ca2+ pools and of protein kinase C.
Huang HY; Hertting G; Allgaier C; Jackisch R
Eur J Pharmacol; 1991 Mar; 206(3):221-30. PubMed ID: 1713165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]